Clinical trials
Phase 2/3 Alzheimer Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Terminated | 8 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Washington University School of Medicine | 6 |
| VA Office of Research and Development | 3 |
| Cerecin | 2 |
| LeonaBio | 2 |
| Novartis Pharmaceuticals | 2 |
| Pfizer | 2 |
| University of Southern California | 2 |
| University of Wisconsin, Madison | 2 |
| Actinogen Medical | 1 |
| Annovis Bio Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 40 |
| Dementia | 16 |
| Brain Diseases | 2 |
| Cognitive Dysfunction | 2 |
| Mental Disorders | 2 |
| Amyloid Neuropathies, Familial | 1 |
| Amyloidosis | 1 |
| Central Nervous System Diseases | 1 |
| Hypertension | 1 |
| Ketosis | 1 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.